Olfactory Ensheathing Cells Transplanted in Lesioned Spinal Cord	1
Olfactory Ensheathing Cells	1
Lesioned Spinal Cord	45
Loss of Spinal Cord Parenchyma	74
Loss	74
Spinal Cord Parenchyma	82
Functional Recovery ENRIQUE VERDU ' ,1 * GUILLERMO GARCI'A	117
Functional Recovery ENRIQUE VERDU ' ,1	117
Functional Recovery ENRIQUE VERDU '	117
,1	153
GUILLERMO GARCI'A	157
ALI'AS ,1 JOAQUIM FORE ' S ,1,2 RUBEN LO ' PEZ-VALES ,1 AND XAVIER NAVARRO1 ABSTRACT We studied the effects of olfactory ensheathing cells -LRB- OECs -RRB- transplanted in a photochemical spinal cord injury in adult rats	175
ALI'AS	175
,1 JOAQUIM FORE '	181
,1,2 RUBEN LO ' PEZ-VALES ,1 AND XAVIER NAVARRO1 ABSTRACT We studied the effects	199
,1,2 RUBEN LO ' PEZ-VALES ,1	199
,1,2 RUBEN LO ' PEZ-VALES	199
,1,2	199
RUBEN LO ' PEZ-VALES	204
RUBEN LO '	204
,1	223
XAVIER NAVARRO1 ABSTRACT We studied the effects	230
XAVIER NAVARRO1 ABSTRACT	230
We	256
the effects	267
olfactory ensheathing cells -LRB- OECs -RRB- transplanted in a photochemical spinal cord injury in adult rats	282
olfactory ensheathing cells	282
OECs	311
a photochemical spinal cord injury in adult rats	333
a photochemical spinal cord injury	333
adult rats	371
dorsal laminectomy at T8 vertebra	389
dorsal laminectomy	389
T8 vertebra	411
subjacent spinal cord	424
Bengal for 10 min	467
Bengal	467
10 min	478
visible light	506
means of an optic fiber connected to a halogen lamp for 2.5 min at maximal intensity of 8 kLux	523
means	523
an optic fiber connected to a halogen lamp for 2.5 min at maximal intensity of 8 kLux	532
an optic fiber	532
a halogen lamp for 2.5 min	560
a halogen lamp	560
2.5 min	579
maximal intensity of 8 kLux	590
maximal intensity	590
8 kLux	611
Eight injured rats	619
a suspension of OECs	647
a suspension	647
OECs	663
DMEM	671
another eight rats	681
DMEM	709
Locomotor ability scored by the BBB scale , pain sensibility by the plantar algesimetry test , and motor - and somatosensory - evoked potentials by electrophysiological techniques	721
Locomotor ability	721
the BBB scale , pain sensibility by the plantar algesimetry test , and motor - and somatosensory - evoked potentials by electrophysiological techniques	749
the BBB scale	749
pain sensibility by the plantar algesimetry test	764
pain sensibility	764
the plantar algesimetry test	784
motor - and somatosensory - evoked potentials by electrophysiological techniques	818
motor - and somatosensory -	818
motor	818
somatosensory	829
potentials	851
electrophysiological techniques	865
3 months postsurgery	916
all rats	947
paraformaldehyde	975
transverse sections from the spinal cord segment at the lesion site	996
transverse sections	996
the spinal cord segment at the lesion site	1021
the spinal cord segment	1021
the lesion site	1048
GFAP	1091
Area of the preserved spinal cord parenchyma	1097
Area	1097
the preserved spinal cord parenchyma	1105
the GFAPimmunolabeled cord sections	1160
the	1160
cord sections	1182
The BBB score and the amplitude of motor - and somatosensory - evoked potentials	1197
The BBB score	1197
the amplitude of motor - and somatosensory - evoked potentials	1215
the amplitude	1215
motor - and somatosensory - evoked potentials	1232
motor	1232
somatosensory	1243
potentials	1265
OECs-transplanted rats	1291
DMEMinjected animals throughout follow-up	1322
DMEMinjected animals	1322
follow-up	1354
the withdrawal response to heat noxious stimulus	1373
the withdrawal response	1373
heat noxious stimulus	1400
lower in OEC	1426
lower	1426
OEC	1435
DMEM-injected rats	1448
The area of preserved spinal cord	1468
The area	1468
preserved spinal cord	1480
OECs-transplanted rats	1530
DMEM-injected animals	1561
These results	1584
OECs	1612
functional and morphological preservation of the spinal cord	1625
functional and morphological preservation	1625
the spinal cord	1670
photochemical injury	1692
INTRODUCTION	1715
lesion to the mammalian spinal cord , injured axons	1734
lesion	1734
the mammalian spinal cord , injured axons	1744
the mammalian spinal cord	1744
axons	1779
the lesion site	1811
synaptic connections	1850
their targets	1876
a consequence	1894
damage to the spinal cord	1909
damage	1909
the spinal cord	1919
permanent deficits	1946
partial or complete paralysis and sensory loss	1976
partial or complete paralysis	1976
sensory loss	2010
the level of lesion	2029
the level	2029
lesion	2042
the last years	2053
numerous studies	2069
the factors that limit spinal cord regeneration	2112
the factors	2112
spinal cord regeneration	2135
different strategies	2174
the repair of such injuries -LRB- Ramer et al. , 2000 -RRB-	2199
the repair	2199
such injuries -LRB- Ramer et al. , 2000 -RRB-	2213
such injuries	2213
Ramer	2228
et al. , 2000	2234
et al.	2234
2000	2242
Most experimental studies	2249
techniques that allow us to induce graded spinal cord injuries , such as weight drop -LRB- Allen , 1911 ; Basso et al. , 1995 -RRB- , aneurysm clip -LRB- Fehlings and Tator , 1995 ; Joshi and Fehlings , 2002a , b -RRB- , and photochemical -LRB- Prado et al. , 1987 -RRB- methods	2285
techniques	2285
us	2307
spinal cord injuries , such as weight drop -LRB- Allen , 1911 ; Basso et al. , 1995 -RRB- , aneurysm clip -LRB- Fehlings and Tator , 1995 ; Joshi and Fehlings , 2002a , b -RRB- , and photochemical -LRB- Prado et al. , 1987 -RRB- methods	2327
spinal cord injuries	2327
weight drop -LRB- Allen , 1911 ; Basso et al. , 1995 -RRB- , aneurysm clip -LRB- Fehlings and Tator , 1995 ; Joshi and Fehlings , 2002a , b -RRB- , and photochemical -LRB- Prado et al. , 1987 -RRB-	2357
weight drop -LRB- Allen , 1911 ; Basso et al. , 1995 -RRB-	2357
weight drop	2357
Allen , 1911 ; Basso et al. , 1995	2370
Allen	2370
1911 ; Basso et al.	2377
1911	2377
Basso et al.	2383
Basso	2383
et al.	2389
1995	2397
aneurysm clip -LRB- Fehlings and Tator , 1995 ; Joshi and Fehlings , 2002a , b -RRB-	2404
aneurysm clip	2404
Fehlings and Tator , 1995 ; Joshi and Fehlings , 2002a , b	2419
Fehlings and Tator	2419
Fehlings	2419
Tator	2432
1995 ; Joshi and Fehlings	2439
1995	2439
Joshi and Fehlings	2445
2002a , b	2465
2002a	2465
b	2472
photochemical -LRB- Prado et al. , 1987 -RRB-	2480
photochemical	2480
Prado	2495
et al. , 1987	2501
et al.	2501
1987	2509
methods	2515
These experimental paradigms	2524
the effects of graded cord injuries on functional recovery and their relationship with histopathological results	2581
the effects	2581
cord injuries	2603
functional recovery and their relationship	2620
functional recovery	2620
their relationship	2644
histopathological results	2668
testing therapies that promote neural protection and axonal regeneration	2703
testing therapies	2703
neural protection and axonal regeneration	2734
neural protection	2734
axonal regeneration	2756
Pharmacological treatments -LRB- Lankhorst et al. , 1999 ; Mu et al. , 2000 ; Yu et al. , 2000 -RRB- , infusion of diffusible growth factors -LRB- McTigue et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002 -RRB- , and cellular transplants -LRB- Paino and Bunge , 1991 ; Mc - Donald et al. , 1999 -RRB-	2777
Pharmacological treatments	2777
Lankhorst et al. , 1999 ; Mu et al. , 2000 ; Yu et al. , 2000 -RRB- , infusion of diffusible growth factors -LRB- McTigue et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002 -RRB- , and cellular transplants -LRB- Paino and Bunge , 1991 ; Mc - Donald et al. , 1999	2805
Lankhorst	2805
et al. , 1999 ; Mu et al. , 2000 ; Yu et al. , 2000 -RRB- , infusion of diffusible growth factors -LRB- McTigue et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002 -RRB- , and cellular transplants -LRB- Paino and Bunge , 1991 ; Mc - Donald et al. , 1999	2815
et al. , 1999	2815
et al.	2815
1999	2823
Mu et al. , 2000	2829
Mu	2829
et al. , 2000	2832
et al.	2832
2000	2840
Yu et al. , 2000 -RRB- , infusion of diffusible growth factors -LRB- McTigue et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002 -RRB- , and cellular transplants -LRB- Paino and Bunge , 1991	2846
Yu et al. , 2000 -RRB-	2846
Yu	2846
et al.	2849
2000	2857
infusion of diffusible growth factors -LRB- McTigue et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002 -RRB-	2864
infusion	2864
diffusible growth factors	2876
McTigue et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002	2903
McTigue	2903
et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002	2911
et al. , 1998	2911
et al.	2911
1998	2919
Ankeny et al. , 2001	2925
Ankeny	2925
et al. , 2001	2932
et al.	2932
2001	2940
Kojima and Tator , 2002	2946
Kojima and Tator	2946
2002	2964
cellular transplants -LRB- Paino and Bunge , 1991	2975
cellular transplants -LRB- Paino and Bunge ,	2975
cellular transplants	2975
Paino and Bunge	2997
Paino	2997
Bunge	3007
1991	3014
Mc - Donald et al. , 1999	3020
Mc	3020
Donald et al. , 1999	3024
Donald	3024
et al. , 1999	3031
et al.	3031
1999	3039
spinal cord lesions	3074
Olfactory ensheathing cells -LRB- OECs -RRB-	3095
Olfactory ensheathing cells	3095
OECs	3124
remyelination of demyelinated spinal axons -LRB- Barnett et al. , 2000 ; Kato et al. , 2000 -RRB- , restore central nerve conduction -LRB- Imaizumi et al. , 1998 , 2000 -RRB- , and promote axonal regeneration -LRB- Li et al. , 1998 ; Imaizumi et al. , 2000 ; Ramo ' n-Cueto et al. , 2000 ; Lu et al. , 2001 , 2002 -RRB- after transplantation in lesioned spinal cords	3137
remyelination	3137
spinal axons -LRB- Barnett et al. , 2000 ; Kato et al. , 2000 -RRB-	3167
spinal axons	3167
Barnett	3181
et al. , 2000 ; Kato et al. , 2000	3189
et al.	3189
2000 ; Kato et al.	3197
2000	3197
Kato et al.	3203
Kato	3203
et al.	3208
2000	3216
central nerve conduction -LRB- Imaizumi et al. , 1998 , 2000 -RRB-	3231
central nerve conduction	3231
Imaizumi	3257
et al. , 1998 , 2000	3266
et al.	3266
1998	3274
2000	3280
axonal regeneration -LRB- Li et al. , 1998 ; Imaizumi et al. , 2000 ; Ramo ' n-Cueto et al. , 2000 ; Lu et al. , 2001 , 2002 -RRB-	3299
axonal regeneration	3299
Li et al. , 1998 ; Imaizumi et al. , 2000 ; Ramo ' n-Cueto et al. , 2000 ; Lu et al.	3320
Li	3320
et al. , 1998 ; Imaizumi et al. , 2000 ; Ramo ' n-Cueto et al. , 2000 ; Lu et al.	3323
et al. , 1998	3323
et al.	3323
1998	3331
Imaizumi et al. , 2000	3337
Imaizumi	3337
et al. , 2000	3346
et al.	3346
2000	3354
Ramo ' n-Cueto et al. , 2000	3360
Ramo ' n-Cueto et al.	3360
Ramo ' n-Cueto	3360
Ramo '	3360
et al.	3373
2000	3381
Lu et al.	3387
Lu	3387
et al.	3390
2001 , 2002	3398
2001	3398
2002	3404
transplantation	3416
lesioned spinal cords	3435
Significant recovery of motor and sensory functions	3458
Significant recovery	3458
motor and sensory functions	3482
OECs-transplanted rats	3526
DMEM-injected animals after complete spinal cord transection -LRB- Ramo ' n-Cueto et al. , 2000 ; Lu et al. , 2001 , 2002 -RRB-	3563
DMEM-injected animals	3563
complete spinal cord transection -LRB- Ramo ' n-Cueto et al. , 2000 ; Lu et al. , 2001 , 2002 -RRB-	3591
complete spinal cord transection	3591
Ramo ' n-Cueto et al. , 2000 ; Lu et al. , 2001 , 2002	3625
Ramo ' n-Cueto et al.	3625
Ramo ' n-Cueto	3625
Ramo '	3625
et al.	3638
2000 ; Lu et al.	3646
2000	3646
Lu et al.	3652
Lu	3652
et al.	3655
2001 , 2002	3663
2001	3663
2002	3669
These findings	3676
OECs	3716
axonal regeneration and functional recovery	3749
regeneration	3756
a severe spinal cord injury	3799
a previous study	3831
we	3849
severe photochemical cord injury	3873
OECs-transplanted rats	3907
significantly lower area of cystic cavity and lower expression of proteoglycan and glial fibrillary acidic protein -LRB- GFAP -RRB-	3937
significantly lower area of cystic cavity	3937
significantly lower area	3937
cystic cavity	3965
lower expression of proteoglycan and glial fibrillary acidic protein -LRB- GFAP -RRB-	3983
lower expression	3983
proteoglycan and glial fibrillary acidic protein -LRB- GFAP -RRB-	4003
proteoglycan	4003
glial fibrillary acidic protein -LRB- GFAP -RRB-	4020
glial fibrillary acidic protein	4020
GFAP	4053
reactive astrocytes in comparison	4062
reactive astrocytes	4062
comparison	4085
nontransplanted animals -LRB- Verdu ' et al. , 2001	4101
nontransplanted animals -LRB- Verdu ' et al.	4101
nontransplanted animals	4101
Verdu ' et al.	4126
Verdu '	4126
et al.	4133
2001	4141
In vitro studies	4148
OECs	4188
GFAP and proteoglycan expression in reactive astrocytes -LRB- Lakatos et al. , 2000 , 2002 -RRB-	4202
GFAP and proteoglycan expression	4202
reactive astrocytes -LRB- Lakatos et al. , 2000 , 2002 -RRB-	4238
reactive astrocytes	4238
Lakatos	4259
et al. , 2000 , 2002	4267
et al.	4267
2000	4275
2002	4281
These results	4288
OECs	4315
a favorable microenvironment	4327
the lesion site that permits the regeneration of central axons	4359
the lesion site	4359
the regeneration of central axons	4388
the regeneration	4388
central axons	4408
the present work	4426
we	4444
the effects of OECs transplants on functional and electrophysiological recovery	4456
the effects	4456
OECs transplants on functional and electrophysiological recovery	4471
OECs transplants	4471
functional and electrophysiological recovery	4491
moderate photochemical spinal cord injury during the first 3 months postoperation	4542
moderate photochemical spinal cord injury	4542
the first 3 months postoperation	4591
Locomotor activity , evaluated using open-field walking	4625
Locomotor activity	4625
open-field walking	4661
sensitivity of the hindpaw	4697
sensitivity	4697
the hindpaw	4712
functional tests	4737
Motor - and somatosensory-evoked potentials	4755
Motor	4755
somatosensory-evoked potentials	4766
the integrity of spinal cord pathways	4823
the integrity	4823
spinal cord pathways	4840
The area of preserved cord parenchyma	4862
The area	4862
preserved cord parenchyma	4874
spinal cord sections immunostained against GFAP	4918
spinal cord sections	4918
GFAP	4961
MATERIALS AND METHODS Culture of OECs , Immunopurification , and Cryopreservation Primary cultures of OECs from adult -LRB- 2.5 - to 3.0 - month-old -RRB- female Sprague-Dawley rats	4968
MATERIALS	4968
METHODS Culture of OECs	4982
METHODS Culture	4982
OECs	5001
Immunopurification	5007
Cryopreservation Primary cultures of OECs from adult -LRB- 2.5 - to 3.0 - month-old -RRB- female Sprague-Dawley rats	5031
Cryopreservation Primary cultures	5031
OECs from adult -LRB- 2.5 - to 3.0 - month-old -RRB- female Sprague-Dawley rats	5068
OECs	5068
adult -LRB- 2.5 - to 3.0 - month-old -RRB- female Sprague-Dawley rats	5078
2.5	5085
3.0	5093
the method described by Gudin˜ o-Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB- with minor modifications	5175
the method	5175
Gudin˜ o-Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB-	5199
Gudin˜ o-Cabrera and Nieto-Sampedro	5199
1996	5236
2000	5242
minor modifications	5253
Olfactory bulbs	5274
Hank 's balanced salt solution -LRB- HBSS ; Sigma -RRB-	5329
Hank 's balanced salt solution	5329
Hank 's	5329
HBSS ; Sigma	5360
HBSS	5360
Sigma	5366
calcium and magnesium	5378
0 °C	5403
The meningeal layer	5408
fine forceps	5450
the bulbs	5468
0.25 % trypsin , 0.1 % collagenase A , and 0.1 % Dnase-I -LRB- Boehringer Mannheim , Germany -RRB-	5496
0.25 % trypsin	5496
0.1 % collagenase A	5511
0.1 % Dnase-I -LRB- Boehringer Mannheim , Germany -RRB-	5535
0.1 % Dnase-I	5535
Boehringer Mannheim	5549
Germany	5570
1 ml HBSS at 37 °C for 45 -- 60 min	5582
1 ml HBSS	5582
37 °C for 45 -- 60 min	5595
37 °C for 45	5595
37 °C	5595
45	5604
60 min	5607
incubation	5621
tissue dissociation	5633
gentle trituration	5665
a flame-constricted Pasteur pipette	5690
enzymes	5732
the addition of 10 ml of Dulbecco 's minimum essential medium nutrient mixture F-12 Ham -LRB- DMEM ; Sigma -RRB- with 10 % fetal calf serum -LRB- FCS , Biological Industries , Israel -RRB-	5760
the addition	5760
10 ml of Dulbecco 's minimum essential medium nutrient mixture F-12 Ham -LRB- DMEM ; Sigma -RRB- with 10 % fetal calf serum -LRB- FCS , Biological Industries , Israel -RRB-	5776
10 ml of Dulbecco 's minimum essential medium nutrient mixture F-12 Ham -LRB- DMEM ; Sigma -RRB- with 10 % fetal calf serum	5776
10 ml of Dulbecco 's minimum essential medium nutrient mixture F-12 Ham -LRB- DMEM ; Sigma -RRB-	5776
10 ml	5776
Dulbecco 's minimum essential medium nutrient mixture F-12 Ham	5785
Dulbecco 's	5785
DMEM ; Sigma	5848
DMEM	5848
Sigma	5854
10 % fetal calf serum	5866
FCS	5888
Biological Industries	5893
Israel	5916
The cell mixture	5925
centrifugation	5959
900 rpm for 7 min	5977
900 rpm	5977
7 min	5989
culture medium	6014
Cells	6030
25 cm2 flasks coated with poly-L-lysine -LRB- 10 µg/ml ; Sigma -RRB- , and incubated in 5 % CO2 at 37 °C	6058
25 cm2 flasks	6058
poly-L-lysine -LRB- 10 µg/ml ; Sigma -RRB-	6084
poly-L-lysine	6084
10 µg/ml ; Sigma	6099
10 µg/ml	6099
Sigma	6109
5 % CO2 at 37 °C	6134
5 % CO2	6134
37 °C	6144
Culture medium	6150
DMEM with 10 % FCS	6169
DMEM	6169
10 % FCS	6179
9 days in vitro	6191
9 days	6191
this medium	6208
a defined medium for expanding OECs -LRB- Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 -RRB-	6236
a defined medium	6236
OECs -LRB- Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 -RRB-	6267
OECs	6267
Gudin˜ o-Cabrera and Nieto-Sampedro , 2000	6273
Gudin˜ o-Cabrera and Nieto-Sampedro	6273
2000	6310
confluency -LRB- about 15 days in culture -RRB-	6332
confluency	6332
15 days in culture	6350
15 days	6350
culture	6361
the cell monolayer	6371
HBSS	6412
calcium and magnesium	6425
4 °C	6451
incubation	6472
trypsin -LRB- 0.05 % w/v -RRB-	6488
trypsin	6488
0.05 % w/v	6497
0.05 %	6497
w/v	6503
EDTA -LRB- 0.02 % ; Sigma -RRB-	6508
EDTA	6508
0.02 % ; Sigma	6514
0.02 %	6514
Sigma	6521
Trypsin action	6529
the addition of medium	6560
the addition	6560
medium	6576
the cell mixture	6587
centrifugation	6621
900 rpm for 7 min	6639
900 rpm	6639
7 min	6651
OECs	6658
mean of magnetic Dynabeads	6686
mean	6686
magnetic Dynabeads	6694
M-450 -LRB- DBM - 450 , Dynal , Oslo -RRB- precoated with goat antimouse IgG and attached with mouse monoclonal 192 IgG antibodies that recognize the p75-NGF receptor -LRB- Chemicon -RRB-	6713
M-450 -LRB- DBM - 450 , Dynal , Oslo -RRB-	6713
M-450	6713
DBM	6720
450 , Dynal , Oslo	6725
450	6725
Dynal , Oslo	6730
goat antimouse IgG	6758
mouse monoclonal 192 IgG antibodies	6795
192	6812
the p75-NGF receptor -LRB- Chemicon -RRB-	6846
the p75-NGF receptor	6846
Chemicon	6868
The cell mixture	6879
DMEM medium	6915
DBM-coated magnetic beads	6946
40 min	6977
The cells selectively attached to the magnetic beads	6998
The cells	6998
the magnetic beads	7032
the cells that did not express p75-NGF receptor with the help of a potent magnet	7071
the cells	7071
p75-NGF receptor	7102
the help of a potent magnet	7124
the help	7124
a potent magnet	7136
The magnet	7153
the complexes of magnetic beads-OECs	7173
the complexes	7173
magnetic beads-OECs	7190
the side of the polypropylene tube	7213
the side	7213
the polypropylene tube	7225
These complexes	7249
DMEM	7282
the unattached p75 negative cells	7300
the unattached p75	7300
negative cells	7319
The p75	7335
positive cells	7344
freezing medium -LRB- Sigma -RRB-	7379
freezing medium	7379
Sigma	7396
4 °C , transferred to a -20 °C freezer for 10 min , then to a deep freezer at -80 °C	7417
4 °C	7417
a -20 °C freezer for 10 min	7437
a -20 °C freezer	7437
10 min	7457
a deep freezer at -80 °C	7473
a deep freezer	7473
-80 °C	7491
transplantation	7502
frozen cell vials	7519
37 °C , washed two times by centrifugation -LRB- 900 rpm , 7 min -RRB- in DMEM	7552
37 °C	7552
two times	7565
centrifugation	7578
900 rpm , 7 min	7594
900 rpm	7594
7 min	7603
DMEM	7613
the pellet	7623
the same medium	7653
The cells	7670
2 h of thawing	7705
2 h	7705
thawing	7712
our conditions	7727
more than 90 % of cells in primary cultures	7743
more than 90 %	7743
cells in primary cultures	7760
cells	7760
primary cultures	7769
spindle-like morphology	7791
two or three processes	7820
less than 10 % of cells	7850
less than 10 %	7850
cells	7867
appearance	7885
A few macrophages/microglial cells	7897
our cultures	7956
accordance with previous studies -LRB- Gudin˜ o-Cabrera and Nieto - Sampedro , 1996 -RRB-	7973
accordance	7973
previous studies -LRB- Gudin˜ o-Cabrera and Nieto - Sampedro , 1996 -RRB-	7989
previous studies	7989
Gudin˜ o-Cabrera and Nieto - Sampedro , 1996	8007
Gudin˜	8007
o-Cabrera and Nieto - Sampedro , 1996	8014
o-Cabrera and Nieto	8014
o-Cabrera	8014
Nieto	8028
Sampedro , 1996	8035
Sampedro	8035
1996	8045
more than 97 % of the immunopurified cells	8052
more than 97 %	8052
the immunopurified cells	8069
the majority of transplanted OECs	8127
the majority	8127
transplanted OECs	8143
spindle-shaped p75-positive cells , described as Schwann-cell-like phenotype -LRB- Franceschini and Barnett , 1996 ; Li et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al. , 2002 -RRB-	8165
spindle-shaped p75-positive cells	8165
Schwann-cell-like phenotype -LRB- Franceschini and Barnett , 1996 ; Li et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al. , 2002 -RRB-	8213
Schwann-cell-like phenotype	8213
Franceschini and Barnett , 1996 ; Li et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al. , 2002	8242
Franceschini and Barnett	8242
1996 ; Li et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al.	8268
1996	8268
Li et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al.	8274
Li	8274
et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al.	8277
et al. , 1998	8277
et al.	8277
1998	8285
Gudin˜ o-Cabrera and Nieto-Sampedro , 2000	8291
Gudin˜ o-Cabrera and Nieto-Sampedro	8291
2000	8328
Wewetzer et al.	8334
Wewetzer	8334
et al.	8343
2002	8351
Animal Surgery Sixteen adult female Sprague-Dawley rats -LRB- 250 -- 300 g -RRB-	8358
Animal Surgery Sixteen adult female Sprague-Dawley rats	8358
Animal Surgery	8358
Sixteen adult female Sprague-Dawley rats	8373
250 -- 300 g	8415
250	8415
300 g	8419
sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	8449
sodium pentobarbital	8449
50 mg/kg , i.p.	8471
50 mg/kg	8471
a heating pad	8507
body temperature constant	8533
The back of the animals	8560
The back	8560
the animals	8572
povidone iodine	8616
a longitudinal incision of the skin and muscles extending from mid to low thoracic vertebrae	8637
a longitudinal incision	8637
the skin and muscles extending from mid to low thoracic vertebrae	8664
the skin and muscles	8664
mid to low thoracic vertebrae	8700
mid	8700
low thoracic vertebrae	8707
The spinal cord	8740
a dorsal laminectomy	8771
T8 vertebra	8795
The dura	8808
penetration of solutions	8849
penetration	8849
solutions	8864
Rose Bengal -LRB- RB ; 1.5 % in saline ; Sigma -RRB-	8875
Rose Bengal	8875
RB ; 1.5 % in saline ; Sigma	8888
RB	8888
1.5 % in saline ; Sigma	8892
1.5 % in saline	8892
1.5 %	8892
saline	8900
Sigma	8908
the exposed spinal cord for 10 min	8939
the exposed spinal cord	8939
10 min	8967
The excess dye	8975
The excess	8975
a double saline rinse	9005
The lesion	9028
the exposed dorsal surface of the spinal cord by means of one optic fiber	9067
the exposed dorsal surface	9067
the spinal cord by means of one optic fiber	9097
the spinal cord	9097
means of one optic fiber	9116
means	9116
one optic fiber	9125
10 mm	9152
top of the cord	9161
top	9161
the cord	9168
The optic fiber	9178
a halogen lamp -LRB- Raypa , Barcelona , Spain -RRB-	9211
a halogen lamp	9211
Raypa	9227
Barcelona	9234
Spain	9245
The spinal cord	9253
maximal intensity of 8 kLux for 2.5 min	9288
maximal intensity	9288
8 kLux for 2.5 min	9309
8 kLux	9309
2.5 min	9320
damage	9340
the calorific source of the halogen lamp	9350
the calorific source	9350
the halogen lamp	9374
the illumination time	9399
the spinal cord	9421
saline solution -LRB- Garcı ' a-Alı ' as et al. , 2002 ; Verdu ' et al. , 2002 -RRB-	9453
saline solution	9453
Garcı ' a-Alı ' as et al. , 2002 ; Verdu ' et al. , 2002	9470
Garcı ' a-Alı ' as et al. , 2002 ; Verdu ' et al. ,	9470
Garcı ' a-Alı	9470
et al.	9485
2002 ; Verdu ' et al. ,	9493
2002	9493
Verdu ' et al.	9499
Verdu '	9499
et al.	9506
2002	9514
Thirty minutes	9521
injury	9542
eight animals	9550
four injections of a suspension of OECs -LRB- 45,000 in 3 µl DMEM -RRB-	9573
four injections	9573
a suspension of OECs -LRB- 45,000 in 3 µl DMEM -RRB-	9592
a suspension	9592
OECs -LRB- 45,000 in 3 µl DMEM -RRB-	9608
OECs	9608
45,000 in 3 µl DMEM	9614
45,000	9614
3 µl DMEM	9624
the exposed spinal cord -LRB- group OEC -RRB-	9640
the exposed spinal cord	9640
group OEC	9665
Each animal	9677
a total of 180,000 OECs	9698
a total	9698
180,000 OECs	9709
DMEM	9725
Another eight rats	9731
four injections of an equal volume of vehicle alone -LRB- group DMEM -RRB-	9759
four injections	9759
an equal volume of vehicle alone -LRB- group DMEM -RRB-	9778
an equal volume	9778
vehicle alone -LRB- group DMEM -RRB-	9797
vehicle alone	9797
group DMEM	9812
The suspension	9825
a glass micropipette	9860
means of repeated 20-ms pulses of 10 psi -LRB- Picospitzer II , General Valve , Fairfield , NJ -RRB- -LRB- Verdu ' et al. , 2001 -RRB-	9884
means	9884
repeated 20-ms pulses of 10 psi -LRB- Picospitzer II , General Valve , Fairfield , NJ -RRB- -LRB- Verdu ' et al. , 2001 -RRB-	9893
repeated 20-ms pulses	9893
10 psi -LRB- Picospitzer II , General Valve , Fairfield , NJ -RRB- -LRB- Verdu ' et al. , 2001 -RRB-	9918
10 psi -LRB- Picospitzer II , General Valve , Fairfield , NJ -RRB-	9918
10 psi	9918
Picospitzer II	9926
General Valve	9942
Fairfield , NJ	9957
Verdu ' et al. , 2001	9973
Verdu '	9973
al.	9983
2001	9988
the wound	10004
the animals	10029
a warm environment	10054
full recovery	10079
Amitriptyline -LRB- 150 µg/ml -RRB-	10094
Amitriptyline	10094
150 µg/ml	10109
the drinking water	10140
neuropathic pain -LRB- Navarro et al. , 1994 -RRB-	10170
neuropathic pain	10170
Navarro	10188
et al. , 1994	10196
et al.	10196
1994	10204
The experimental procedures	10211
the recommendations of the European Union and the U.S. Department of Health	10250
the recommendations of the European Union	10250
the recommendations	10250
the European Union	10273
the U.S. Department of Health	10296
the U.S. Department	10296
Health	10319
the care and use of laboratory animals	10330
the care and use	10330
laboratory animals	10350
the ethics committee of our institution	10390
the ethics committee	10390
our institution	10414
Functional Methods Functional tests	10431
Functional Methods	10431
Functional tests	10450
operation	10489
7 , 14 , 21 , 30 , 45 , 60 , and 90 days	10506
7	10506
14	10509
21	10513
30	10517
45	10521
60	10525
90 days	10533
postoperation	10541
Locomotor activity	10556
the open-field walking scoring system	10595
the locomotor ability for 5 min	10647
the locomotor ability	10647
5 min	10673
One animal at a time	10680
One animal	10680
a time	10694
a circular plastic tray -LRB- 90 cm diameter x 24 cm wall height -RRB-	10735
a circular plastic tray	10735
90 cm diameter x 24 cm wall height	10760
90 cm diameter	10760
24 cm wall height	10777
Two independent examiners	10797
the hindlimb movements of the rat	10832
the hindlimb movements	10832
the rat	10858
the locomotor function	10877
the BBB scale -LRB- Basso et al. , 1995 -RRB-	10913
the BBB scale	10913
Basso	10928
et al. , 1995	10934
et al.	10934
1995	10942
The final score of each animal	10949
The final score	10949
each animal	10968
the mean value of both examiners	10984
the mean value	10984
both examiners	11002
The BBB scale	11018
0 -LRB- no hindlimb movement -RRB-	11044
0	11044
no hindlimb movement	11047
21 -LRB- normal movement-coordinated gait -RRB-	11072
21	11072
normal movement-coordinated gait	11076
Animals	11111
testing	11142
the inclined - plane method -LRB- Rivlin and Tator , 1977 -RRB-	11153
the inclined	11153
plane method -LRB- Rivlin and Tator , 1977 -RRB-	11167
plane method	11167
Rivlin and Tator , 1977	11181
Rivlin	11181
Tator , 1977	11192
Tator	11192
1977	11199
The maximum angle at which the animal could maintain a stable position for 5 s on the inclined plane	11206
The maximum angle	11206
the animal	11233
a stable position	11259
5 s on the inclined plane	11281
5 s	11281
the inclined plane	11288
Nociceptive sensitivity	11321
a heat radiation method	11362
a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	11392
a plantar algesimeter	11392
Hargreaves	11415
et al. , 1988	11426
et al.	11426
1988	11434
the rat	11450
a plastic box	11474
an elevated glass floor	11493
the bottom of the box	11523
the bottom	11523
the box	11537
the light of a projection lamp -LRB- 150 W -RRB-	11546
the light	11546
a projection lamp -LRB- 150 W -RRB-	11559
a projection lamp	11559
150 W	11578
the plantar surface of the hindpaw	11611
the plantar surface	11611
the hindpaw	11634
The time to withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11647
The time	11647
withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11659
withdrawal	11659
the heated paw -LRB- withdrawal latency -RRB-	11673
the heated paw	11673
withdrawal latency	11689
a time meter coupled with infrared detectors directed to the plantar surface	11730
a time meter	11730
infrared detectors directed to the plantar surface	11756
infrared detectors	11756
the plantar surface	11787
The maximal time of stimulation	11808
The maximal time	11808
stimulation	11828
40 s	11855
skin damage	11869
The value for a test	11882
The value	11882
a test	11896
the mean of three trials separated by 5-min resting periods	11907
the mean	11907
three trials separated by 5-min resting periods	11919
three trials	11919
5-min resting periods	11945
Electrophysiological Methods Motor - and somatosensory-evoked potentials were tested to evaluate the integrity of spinal cord descending and ascending tracts .	11968
Electrophysiological Methods	11968
Motor - and somatosensory-evoked potentials	11997
Motor	11997
somatosensory-evoked potentials	12008
the integrity of spinal cord	12064
the integrity	12064
spinal cord	12081
tracts	12118
Animals	12126
sodium pentobarbital	12157
25 mg/kg , i.p.	12179
25 mg/kg	12179
a prone position over a warmed flat coil controlled by a hot-water circulating pump to maintain skin temperature above 32 °C	12209
a prone position	12209
a warmed flat coil controlled by a hot-water circulating pump to maintain skin temperature above 32 °C	12231
a warmed flat coil	12231
a hot-water circulating pump to maintain skin temperature above 32 °C	12264
a hot-water	12264
pump	12288
skin temperature	12305
32 °C	12328
Motor-evoked potentials -LRB- MEPs -RRB-	12334
Motor-evoked potentials	12334
MEPs	12359
monopolar needle electrodes placed at the tibialis anterior muscle	12385
monopolar needle electrodes	12385
the tibialis anterior muscle	12423
the contralateral sensorimotor cortex	12459
single rectangular pulses of 0.1-ms duration	12515
single rectangular pulses	12515
0.1-ms duration	12544
needle electrodes inserted subcutaneously , the cathode over the skull overlying the sensorimotor cortex	12579
needle electrodes	12579
the cathode over the skull overlying the sensorimotor cortex	12622
the cathode	12622
the skull overlying the sensorimotor cortex	12639
the skull	12639
the sensorimotor cortex	12659
the anode	12687
the nose	12700
This configuration	12710
transcranial stimulation that activates subcortical efferent pathways -LRB- Zappulla et al 1988 ; Adamson et al 1989 -RRB-	12738
transcranial stimulation	12738
subcortical efferent pathways -LRB- Zappulla et al 1988 ; Adamson et al 1989 -RRB-	12778
subcortical efferent pathways	12778
Zappulla	12809
et al 1988 ; Adamson et al 1989	12818
et al 1988 ; Adamson et al	12818
et al 1988	12818
et al	12818
1988	12824
Adamson et al	12830
Adamson	12830
et al	12838
1989	12844
somatosensory-evoked potentials -LRB- SSEPs -RRB-	12855
somatosensory-evoked potentials	12855
SSEPs	12888
electrical stimuli 0.1 ms in duration and 4 mA in intensity	12896
electrical stimuli 0.1 ms in duration	12896
electrical stimuli	12896
0.1 ms in duration	12915
0.1 ms	12915
duration	12925
4 mA in intensity	12938
4 mA	12938
intensity	12946
5 Hz to the tibial nerve	12972
5 Hz	12972
the tibial nerve	12980
means of two needle electrodes inserted at the ankle	13000
means	13000
two needle electrodes inserted at the ankle	13009
two needle electrodes	13009
the ankle	13043
responses	13061
two needle electrodes	13091
the skull	13138
same sites as stimulation needles for MEPs	13149
same sites	13149
stimulation needles for MEPs	13163
stimulation needles	13163
MEPs	13187
A total of 256 responses	13194
A total	13194
256 responses	13205
100 ms following each stimulus	13240
100 ms	13240
each stimulus	13257
The signals	13285
bandpass 1 Hz/5 kHz for MEPs and 10 Hz/1 kHz for SSEPs	13323
bandpass 1 Hz/5 kHz for MEPs	13323
bandpass 1 Hz/5 kHz	13323
MEPs	13347
10 Hz/1 kHz for SSEPs	13356
10 Hz/1 kHz	13356
SSEPs	13372
the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude and the latency of the evoked potentials -LRB- Nuwer , 1998 -RRB-	13397
the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude	13397
Sapphire 4ME	13415
Vickers	13429
the amplitude	13449
the latency of the evoked potentials -LRB- Nuwer , 1998 -RRB-	13467
the latency	13467
the evoked potentials -LRB- Nuwer , 1998 -RRB-	13482
the	13482
potentials -LRB- Nuwer , 1998 -RRB-	13493
potentials	13493
Nuwer	13505
1998	13512
reproducibility	13529
the recording and stimulating needles	13546
the recording	13546
stimulating needles	13564
a microscope	13602
the same placement	13625
all animals guided by anatomical landmarks	13647
all animals	13647
anatomical landmarks	13669
All electrophysiological tests	13691
operation	13744
14 , 30 , 60 , and 90 days	13761
14	13761
30	13765
60	13769
90 days	13777
postoperation	13785
Immunohistochemical Methods	13800
the end of functional and electrophysiological tests	13831
the end	13831
functional and electrophysiological tests	13842
the animals	13885
4 % paraformaldehyde in phosphate - buffer saline solution -LRB- PBS , 0.1 M , pH 7.4 -RRB-	13948
4 % paraformaldehyde	13948
phosphate - buffer saline solution -LRB- PBS , 0.1 M , pH 7.4 -RRB-	13971
phosphate	13971
buffer saline solution	13982
PBS	14006
0.1 M	14011
pH 7.4	14018
The spinal cords	14027
the same solution for 24 h	14067
the same solution	14067
24 h	14089
several segments	14110
All spinal cord segments	14128
PBS	14175
30 % sucrose	14190
4 °C	14216
Serial cryotome transverse sections 40 µm thick from the spinal cord segment subjacent to T8 vertebra	14221
Serial cryotome transverse sections	14221
40 µm	14257
the spinal cord segment subjacent	14274
T8 vertebra	14311
free floating in PBS with 0.3 % Triton-X-100 -LRB- Fluka -RRB- and 1 % fetal calf serum -LRB- Biological Industries , Israel -RRB- for 1 h	14335
free floating	14335
PBS with 0.3 % Triton-X-100 -LRB- Fluka -RRB- and 1 % fetal calf serum -LRB- Biological Industries , Israel -RRB-	14352
PBS with 0.3 % Triton-X-100 -LRB- Fluka -RRB-	14352
PBS	14352
0.3 % Triton-X-100 -LRB- Fluka -RRB-	14361
0.3 % Triton-X-100	14361
Fluka	14380
1 % fetal calf serum -LRB- Biological Industries , Israel -RRB-	14391
1 %	14391
fetal calf serum -LRB- Biological Industries , Israel -RRB-	14394
fetal calf serum	14394
Biological Industries , Israel	14412
Biological Industries	14412
Israel	14435
1 h	14447
24 h at 4 °C with rabbit antisera	14469
24 h	14469
4 °C with rabbit antisera	14477
4 °C	14477
rabbit antisera	14486
GFAP -LRB- 1:1,000 , Chemicon -RRB-	14505
GFAP	14505
1:1,000	14511
Chemicon	14520
washes	14537
sections	14545
secondary antiserum , donkey antirabbit Cy3-labeled immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB- overnight	14574
secondary antiserum	14574
donkey antirabbit Cy3-labeled immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB- overnight	14595
donkey antirabbit Cy3-labeled immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB-	14595
donkey antirabbit	14595
Cy3-labeled immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB-	14613
Cy3-labeled immunoglobulin G	14613
1:200	14643
Jackson Immunoresearch	14650
4 °C	14687
additional washes	14702
sections	14721
gelatin-coated slides	14746
ethanol	14783
DPX	14809
a specificity control	14817
some spinal cord sections	14840
primary antibody	14889
Samples	14940
an Olympus BX-51 microscope equipped with epifluorescence using appropriate filters	14966
an Olympus BX-51 microscope	14966
epifluorescence	15008
appropriate filters	15030
Low-power magnification -LRB- x4 -RRB- images of spinal cord sections	15051
Low-power magnification -LRB- x4 -RRB- images	15051
x4	15076
spinal cord sections	15090
the aid of a digital camera -LRB- Olympus DP50 -RRB- attached to the microscope and analyzed using NIH Image software	15127
the aid	15127
a digital camera -LRB- Olympus DP50 -RRB- attached to the microscope and analyzed using NIH Image software	15138
a digital camera	15138
Olympus DP50	15156
the microscope	15182
NIH Image software	15216
Spinal cord sections stained against GFAP	15236
Spinal cord sections	15236
GFAP	15273
the area of preserved cord parenchyma	15302
the area	15302
preserved cord parenchyma	15314
high-intensity staining	15349
reactive astrocytes	15389
the destroyed parenchyma	15436
Two independent subjects	15462
these measurements	15492
the same images	15516
the final area of preserved cord parenchyma of each transverse sections analyzed	15537
the final area	15537
preserved cord parenchyma of each transverse sections analyzed	15555
preserved cord parenchyma	15555
each transverse sections analyzed	15584
each transverse sections	15584
the mean value of both subjects	15622
the mean value	15622
both subjects	15640
Between 8 and 10 transverse spinal cord sections per animal	15655
Between 8 and 10 transverse spinal cord sections	15655
animal	15708
Statistical Analysis All functional , electrophysiological , and histological measurements	15729
Statistical Analysis	15729
All	15750
histological measurements	15792
a blinded manner	15836
A code of rats and histological slices	15854
A code	15854
rats and histological slices	15864
rats	15864
histological slices	15873
Data	15903
mean ± SEM	15921
Statistical comparisons between groups	15933
Statistical comparisons	15933
groups	15965
analysis of variance -LRB- ANOVA -RRB-	15985
analysis	15985
variance -LRB- ANOVA -RRB-	15997
variance	15997
ANOVA	16007
a posthoc Scheffe ' test for multiple comparisons	16019
a posthoc Scheffe ' test	16019
multiple comparisons	16047
specific differences between preand postoperative times	16080
specific differences	16080
preand postoperative times	16109
a paired t-test	16137
Differences	16163
P	16206
RESULTS	16217
1	16230
Evolution of -LRB- A -RRB- the locomotor activity	16233
Evolution	16233
A	16247
the locomotor activity	16250
the BBB	16286
score , -LRB- B -RRB- the maximum angle in the inclined plane test , and -LRB- C -RRB- the time to withdrawal of the heated paw in the plantar algesimetry test over time in the DMEM -LRB- opened circle -RRB- and OECs -LRB- filled circle -RRB- experimental groups	16294
score , -LRB- B -RRB- the maximum angle in the inclined plane test , and -LRB- C -RRB- the time to withdrawal of the heated paw in the plantar algesimetry test over time in the DMEM -LRB- opened circle -RRB- and OECs	16294
score	16294
B	16302
the maximum angle in the inclined plane test , and -LRB- C -RRB- the time to withdrawal of the heated paw in the plantar algesimetry test over time in the DMEM -LRB- opened circle -RRB- and OECs	16305
the maximum angle in the inclined plane test	16305
the maximum angle	16305
the inclined plane test	16326
-LRB- C -RRB- the time to withdrawal of the heated paw in the plantar algesimetry test over time in the DMEM -LRB- opened circle -RRB- and OECs	16355
the time	16359
withdrawal of the heated paw in the plantar algesimetry test over time in the DMEM -LRB- opened circle -RRB- and OECs	16371
withdrawal of the heated paw in the plantar algesimetry test over time in the DMEM	16371
withdrawal	16371
the heated paw in the plantar algesimetry test over time in the DMEM	16385
the heated paw	16385
the plantar algesimetry test over time in the DMEM	16403
the plantar algesimetry test	16403
time in the DMEM	16437
time	16437
the DMEM	16445
circle	16462
OECs	16474
circle	16487
experimental groups	16495
P < 0.05 -LRB- asterisk -RRB- vs. DMEM group .	16516
P <	16516
P	16516
0.05 -LRB- asterisk -RRB- vs. DMEM group	16520
0.05 -LRB- asterisk -RRB-	16520
vs. DMEM group	16536
Fig. 2 .	16553
Fig.	16553
2	16558
electrophysiological recordings of -LRB- A -RRB- MEPs and -LRB- B -RRB- SSEPs	16568
electrophysiological recordings of -LRB- A -RRB- MEPs	16568
electrophysiological recordings	16568
-LRB- A -RRB- MEPs	16603
A	16604
B	16617
SSEPs	16620
rats of groups DMEM -LRB- left -RRB- and OECs -LRB- right -RRB- at 0 , 30 , and 90 days postinjury	16629
rats of groups DMEM -LRB- left -RRB- and OECs -LRB- right -RRB-	16629
rats	16629
groups DMEM -LRB- left -RRB- and OECs -LRB- right -RRB-	16637
groups DMEM	16637
left	16650
OECs	16660
right	16666
0 , 30 ,	16676
0	16676
30	16679
90 days	16687
N1 , first negative wave complex ; N2 , second negative wave complex ; N3 , third negative wave complex .	16707
N1 , first negative wave complex	16707
N1	16707
first negative wave complex	16711
N2 , second negative wave complex	16740
N2	16740
second negative wave complex	16744
N3 , third negative wave complex	16774
N3	16774
third negative wave complex	16778
Horizontal scale , 5 ms ; vertical scale , 4 mV for all MEP recordings .	16807
Horizontal scale , 5 ms	16807
Horizontal scale	16807
5 ms	16825
vertical scale , 4 mV for all MEP recordings	16831
vertical scale	16831
4 mV for all MEP recordings	16847
4 mV	16847
all MEP recordings	16856
Horizontal scale , 10 ms ; vertical scale , 3 µV for all SSEP recordings .	16876
Horizontal scale , 10 ms	16876
Horizontal scale	16876
10 ms	16894
vertical scale , 3 µV for all SSEP recordings	16901
vertical scale	16901
3 µV for all SSEP recordings	16917
3 µV	16917
all SSEP recordings	16926
Fig. 3 .	16948
Fig.	16948
3	16953
Histogram representation of the amplitude -LRB- top -RRB- and latency -LRB- bottom -RRB- over time of the MEPs	16956
Histogram representation	16956
the amplitude -LRB- top -RRB- and latency -LRB- bottom -RRB-	16984
the amplitude	16984
top	16999
latency	17008
bottom	17017
time of the MEPs	17030
time	17030
the MEPs	17038
the tibialis	17059
anterior muscle in the DMEM -LRB- opened bar -RRB- and OECs -LRB- filled bar -RRB- groups	17072
anterior muscle in the DMEM -LRB- opened bar -RRB- and OECs	17072
anterior muscle in the DMEM -LRB- opened bar -RRB-	17072
anterior muscle in the DMEM	17072
anterior muscle	17072
the DMEM	17091
bar	17108
OECs	17117
bar	17130
groups	17135
P < 0.05 -LRB- asterisk -RRB- vs. DMEM group ; -LRB- section symbol -RRB- vs. preoperative values from the same experimental group .	17143
P <	17143
P	17143
0.05 -LRB- asterisk -RRB- vs. DMEM group ; -LRB- section symbol -RRB- vs. preoperative values from the same experimental group	17147
0.05 -LRB- asterisk -RRB- vs. DMEM group	17147
0.05 -LRB- asterisk -RRB-	17147
vs. DMEM group	17163
section symbol	17180
preoperative values from the same experimental group	17200
preoperative values	17200
the same experimental group	17225
Fig. 4 .	17255
Fig.	17255
4	17260
Histogram	17263
of the amplitudes of the N1 -LRB- top -RRB- , N2 -LRB- middle -RRB- , and N3 -LRB- bottom -RRB- waves of SSEPs over time in DMEM -LRB- opened bar -RRB- and OECs -LRB- filled bar -RRB- groups	17288
of the amplitudes of the N1 -LRB- top -RRB- , N2 -LRB- middle -RRB- , and N3 -LRB- bottom -RRB- waves of SSEPs over time in DMEM -LRB- opened bar -RRB- and OECs	17288
the amplitudes of the N1 -LRB- top -RRB- , N2 -LRB- middle -RRB- , and N3 -LRB- bottom -RRB-	17291
the amplitudes	17291
the N1 -LRB- top -RRB- , N2 -LRB- middle -RRB- , and N3 -LRB- bottom -RRB-	17309
the N1 -LRB- top -RRB-	17309
the N1	17309
top	17317
N2 -LRB- middle -RRB-	17323
N2	17323
middle	17327
N3 -LRB- bottom -RRB-	17340
N3	17340
bottom	17344
waves	17352
SSEPs over time in DMEM -LRB- opened bar -RRB- and OECs	17361
SSEPs over time in DMEM	17361
SSEPs	17361
time in DMEM	17372
time	17372
DMEM	17380
bar	17393
OECs	17402
bar	17415
groups	17420
P < 0.05 -LRB- asterisk -RRB- vs. DMEM group ; -LRB- section symbol -RRB- vs. preoperative values from the same experimental group .	17428
P <	17428
P	17428
0.05 -LRB- asterisk -RRB- vs. DMEM group ; -LRB- section symbol -RRB- vs. preoperative values from the same experimental group	17432
0.05 -LRB- asterisk -RRB- vs. DMEM group	17432
0.05 -LRB- asterisk -RRB-	17432
vs. DMEM group	17448
section symbol	17465
preoperative values from the same experimental group	17485
preoperative values	17485
the same experimental group	17510
Fig. 5 .	17540
Fig.	17540
5	17545
Spinal cord sections	17548
GFAP taken at the lesion site segment from the DMEM -LRB- A -RRB- and OECs -LRB- B -RRB- groups	17591
GFAP	17591
the lesion site segment	17605
the DMEM -LRB- A -RRB- and OECs -LRB- B -RRB- groups	17634
the DMEM -LRB- A -RRB-	17634
the DMEM	17634
A	17644
OECs -LRB- B -RRB- groups	17651
OECs	17651
B	17657
groups	17660
Confocal images of astrocytes	17668
Confocal images	17668
astrocytes	17687
GFAP in the gray matter of DMEM -LRB- C -RRB- and OECs -LRB- D -RRB- experimental groups	17720
GFAP	17720
the gray matter of DMEM -LRB- C -RRB- and OECs -LRB- D -RRB- experimental groups	17728
the gray matter of DMEM -LRB- C -RRB-	17728
the gray matter	17728
DMEM -LRB- C -RRB-	17747
DMEM	17747
C	17753
OECs -LRB- D -RRB- experimental groups	17760
OECs	17760
D	17766
experimental groups	17769
Bar : A and B , 1,000 µm ; C and D , 25 µm .	17790
Bar	17790
A and B , 1,000 µm	17795
A and B	17795
1,000 µm	17804
C and D , 25 µm	17814
C and D	17814
25 µm	17823
the first week postoperation	17838
rats transplanted with OECs	17868
rats	17868
OECs	17891
their body weight	17907
rats injected with DMEM	17932
rats	17932
DMEM	17951
a decrease of their body weight	17969
a decrease	17969
their body weight	17983
14 to 90 days postoperation	18007
all animals of both experimental groups	18036
all animals	18036
both experimental groups	18051
weight	18090
Functional Results	18098
the spinal cord lesions	18124
all animals	18149
normal locomotor behavior -LRB- scored 21 -RRB-	18168
normal locomotor behavior	18168
21	18202
7 days postoperation	18210
both experimental groups	18235
the BBB score	18260
respect	18289
preoperative values	18300
the mean score value	18321
about 11 and 16 in the DMEM and the OEC group -LRB- P 0.05 -RRB-	18346
about 11 and 16	18346
the DMEM and the OEC group -LRB- P 0.05 -RRB-	18365
the DMEM	18365
the OEC group -LRB- P 0.05 -RRB-	18378
the OEC group	18378
P 0.05	18393
the following weeks	18425
the BBB score	18446
values	18491
18 and 19	18504
DMEM and OEC rats	18517
90 days postoperation -LRB- Fig. 1A -RRB-	18553
90 days postoperation	18553
Fig. 1A	18576
spite of the fact that the BBB score values were slightly higher in OEC rats with respect to DMEM animals	18589
spite	18589
the fact that the BBB score values were slightly higher in OEC rats with respect to DMEM animals	18598
the fact	18598
the BBB score values	18612
OEC rats	18657
respect	18671
DMEM animals	18682
no significant differences	18696
the two groups	18741
14 to 90 days postoperation	18761
The preoperative mean values of the maximum angle in the inclined plane	18790
The preoperative mean values	18790
the maximum angle in the inclined plane	18822
the maximum angle	18822
the inclined plane	18843
47 °	18873
7 days postoperation	18881
the mean maximum angle	18903
36 °	18939
39 ° in DMEM and OECs rats , then	18947
39 ° in DMEM	18947
39 °	18947
DMEM	18954
OECs rats , then	18963
OECs	18963
rats	18968
mean values of 43 ° and 45 ° in DMEM and OEC groups	19012
mean values of 43 °	19012
mean values	19012
43 °	19027
45 ° in DMEM and OEC groups	19035
45 °	19035
DMEM and OEC groups	19042
90 days postoperation	19065
all postoperative days	19095
the mean maximum angle	19119
OEC	19187
DMEM animals -LRB- Fig. 1B -RRB-	19199
DMEM animals	19199
Fig. 1B	19213
Nociceptive withdrawal responses evaluated by plantar algesimetry	19223
Nociceptive withdrawal responses	19223
plantar algesimetry	19269
a latency of about 15 s in both experimental groups	19293
a latency	19293
about 15 s in both experimental groups	19306
about 15 s	19306
both experimental groups	19320
lesion	19352
7 days postoperation	19363
the time of withdrawal of the heated paw	19385
the time	19385
withdrawal of the heated paw	19397
withdrawal	19397
the heated paw	19411
group DMEM with respect	19439
group DMEM	19439
respect	19455
preoperative values	19466
it	19495
preoperative values in OEC rats	19513
preoperative values	19513
OEC rats	19536
the next 3 weeks	19553
the withdrawal latency	19571
values about 24 and 19 s	19607
values	19607
24 and 19 s	19620
groups DMEM and OEC	19635
Significant differences	19656
groups OEC and DMEM for all postoperative days tested -LRB- Fig. 1C -RRB-	19698
groups OEC and DMEM	19698
all postoperative days tested	19722
all postoperative days	19722
Fig. 1C	19753
Electrophysiological Results The MEPs recorded prior to operation	19763
Electrophysiological Results	19763
The MEPs	19792
operation	19819
a single wave	19836
a mean latency of about 6 ms	19855
a mean latency	19855
6 ms	19879
amplitude of about 15 mV	19893
amplitude	19893
about 15 mV	19906
both groups -LRB- Fig. 2A -RRB-	19921
both groups	19921
Fig. 2A	19934
photochemical injury	19950
no changes in the latency	19972
no changes	19972
the latency	19986
the 90 days postoperation , while the amplitude decreased markedly in group DMEM	20019
the 90 days postoperation	20019
the amplitude	20052
group DMEM	20088
14 days postoperation	20103
MEPs	20126
five of eight DMEM rats	20148
five	20148
eight DMEM rats	20156
a mean amplitude of about 1 mV , and in all OEC rats	20181
a mean amplitude	20181
about 1 mV , and in all OEC rats	20201
1 mV	20207
a mean value amplitude of about 12 mV	20238
a mean value amplitude	20238
12 mV	20270
90 days postoperation	20280
MEPs	20303
three of eight DMEM rats	20330
three	20330
eight DMEM rats	20339
a mean amplitude value of about 0.03 mV	20360
a mean amplitude value	20360
0.03 mV	20392
all rats from the OEC experimental group	20407
all rats	20407
the OEC experimental group	20421
MEP responses	20455
a mean amplitude of about 15 mV	20474
a mean amplitude	20474
about 15 mV	20494
Significant differences	20507
DMEM and OEC groups	20550
all the postoperative days studied -LRB- Fig. 3 -RRB-	20573
all the postoperative days	20573
Fig. 3	20609
Control SSEPs	20618
a series of well-defined negative peaks	20639
a series	20639
well-defined negative peaks	20651
latencies of 14 , 21 , and 30 ms , named N1 , N2 , and N3 waves , with mean amplitudes of about 13 , 16 , and 12 µV , respectively -LRB- Fig. 2B -RRB-	20682
latencies of 14	20682
latencies	20682
14	20695
21	20699
30 ms , named N1 , N2 , and N3 waves , with mean amplitudes of about 13 , 16 , and 12 µV , respectively -LRB- Fig. 2B -RRB-	20707
30 ms , named N1 , N2 , and N3 waves , with mean amplitudes of about 13 , 16 , and 12 µV , respectively	20707
30 ms	20707
N1 , N2 , and N3 waves , with mean amplitudes of about 13 ,	20720
N1	20720
N2 , and N3 waves , with mean amplitudes of about 13	20724
N2 , and N3 waves ,	20724
N2	20724
N3 waves	20732
mean amplitudes of about 13	20747
mean amplitudes	20747
about 13	20766
16 , and 12 µV , respectively	20776
16	20776
12 µV	20784
Fig. 2B	20805
14 days postoperation	20818
the amplitude of all three waves of the SSEPs	20841
the amplitude	20841
all three waves of the SSEPs	20858
all three waves	20858
the SSEPs	20877
respect	20916
preoperative values in both experimental groups	20927
preoperative values	20927
both experimental groups	20950
the amplitude of SSEPs	20985
the amplitude	20985
SSEPs	21002
group OEC	21036
group DMEM	21054
14 to 90 days postoperation -LRB- Fig. 4 -RRB-	21070
14 to 90 days postoperation	21070
Fig. 4	21099
injury	21114
no changes in the latency of the SSEPs	21122
no changes	21122
the latency of the SSEPs	21136
the latency	21136
the SSEPs	21151
Immunohistochemical Results	21176
group DMEM	21207
transverse GFAP-immunostained spinal cord sections from T8 spinal cord segment	21219
transverse GFAP-immunostained spinal cord sections	21219
T8 spinal cord segment	21275
an open cavity affecting the dorsal , dorsolateral , and ventrolateral funiculi up to canal central , while ventral funiculi , including gray matter of the ventral horns , remained intact	21305
an open cavity	21305
the dorsal , dorsolateral , and ventrolateral funiculi	21330
the dorsal	21330
dorsolateral	21342
ventrolateral funiculi	21360
canal central , while ventral funiculi , including gray matter of the ventral horns , remained intact	21389
canal central	21389
ventral funiculi , including gray matter of the ventral horns ,	21410
ventral funiculi	21410
gray matter of the ventral horns	21438
gray matter	21438
the ventral horns	21453
spinal cord parenchyma remains	21499
spinal cord parenchyma	21499
dorsal areas -LRB- Fig. 5A -RRB-	21543
dorsal areas	21543
Fig. 5A	21557
animals of group OEC	21570
animals	21570
group OEC	21581
desestructuration of the dorsal cord parenchyma	21592
desestructuration	21592
the dorsal cord parenchyma	21613
microcavities affecting the white and gray matter and enlargement of the central canal -LRB- Fig. 5B -RRB-	21655
microcavities	21655
the white and gray matter and enlargement of the central canal -LRB- Fig. 5B -RRB-	21679
the white and gray matter	21679
enlargement of the central canal -LRB- Fig. 5B -RRB-	21709
enlargement	21709
the central canal -LRB- Fig. 5B -RRB-	21724
the central canal	21724
Fig. 5B	21743
The	21753
area of preserved spinal cord	21766
area	21766
preserved spinal cord	21774
4.15 ± 0.12 and 4.85 ± 0.12 mm2 in DMEM and OEC groups	21800
4.15 ± 0.12 and 4.85	21800
4.15	21800
0.12 and 4.85	21807
0.12 mm2 in DMEM and OEC groups	21823
0.12 mm2	21823
DMEM and OEC groups	21835
P < 0.001	21870
P	21870
< 0.001	21872
<	21872
0.001	21874
all rats	21885
hypertrophied astrocytes , heavily stained for GFAP ,	21895
hypertrophied astrocytes	21895
GFAP	21941
the cavity or the desestructured cord parenchyma	21964
the cavity	21964
the desestructured cord parenchyma	21978
The spinal cord parenchyma from DMEM rats	22014
The spinal cord parenchyma	22014
DMEM rats	22046
higher number of reactive hypertrophied astrocytes	22063
higher number	22063
reactive hypertrophied astrocytes	22080
long and robust processes extending in all directions and heavily stained for GFAP -LRB- Fig. 5C -RRB-	22120
long and robust processes	22120
all directions	22159
GFAP -LRB- Fig. 5C -RRB-	22198
GFAP	22198
Fig. 5C	22204
OECs-transplanted rats	22217
few astrocytes	22241
a hypertrophied appearance	22263
most	22295
slightly GFAP-stained cell bodies	22307
thin processes -LRB- Fig. 5D -RRB-	22346
thin processes	22346
Fig. 5D	22362
DISCUSSION The results of this study	22373
DISCUSSION The results	22373
DISCUSSION	22373
The results	22384
this study	22399
transplantation of OECs in the site of a moderate photochemical injury to the rat spinal cord	22420
transplantation	22420
OECs in the site of a moderate photochemical injury to the rat spinal cord	22439
OECs	22439
the site of a moderate photochemical injury to the rat spinal cord	22447
the site	22447
a moderate photochemical injury to the rat spinal cord	22459
a moderate photochemical injury	22459
the rat spinal cord	22494
the loss of cord parenchyma	22538
the loss	22538
cord parenchyma	22550
the functional outcome	22579
3 months postinjury	22609
comparison with rats that received an injection of medium	22633
comparison	22633
rats that received an injection of medium	22649
rats	22649
an injection of medium	22668
an injection	22668
medium	22684
OECs-transplanted rats	22692
better locomotor function	22722
normal nociceptive responses	22762
Electrophysiological results	22792
the amplitude of the motor - and somatosensory-evoked potentials	22835
the amplitude	22835
the motor - and somatosensory-evoked potentials	22852
the motor	22852
somatosensory-evoked potentials	22867
OECs	22927
DMEM-injected rats	22941
evidence of functional preservation of descending and ascending spinal pathways	22971
evidence	22971
functional preservation of descending and ascending spinal pathways	22983
functional preservation	22983
spinal pathways	23035
the majority of human spinal cord injuries	23055
the majority	23055
human spinal cord injuries	23071
the mechanism of the primary injury	23099
the mechanism	23099
the primary injury	23116
acute compression or laceration of the spinal cord due to displacement of bone or disk into the spinal cord during fracture-dislo - cation or burst fracture of the spine -LRB- Tator , 1983 -RRB-	23138
acute compression or laceration	23138
the spinal cord	23173
displacement of bone or disk	23196
displacement	23196
bone or disk	23212
the spinal cord	23230
cation or burst fracture of the spine -LRB- Tator , 1983 -RRB-	23269
cation or burst fracture	23269
the spine -LRB- Tator , 1983 -RRB-	23297
the spine	23297
Tator	23308
1983	23315
patients with acute spinal cord injury	23325
patients	23325
acute spinal cord injury	23339
the mechanical injury	23365
the cord	23404
there	23435
loss of neural functions	23453
loss	23453
neural functions	23461
the level of injury -LRB- Kakulas , 1984 ; Geisler et al. , 1991 -RRB-	23488
the level	23488
injury -LRB- Kakulas , 1984 ; Geisler et al. , 1991 -RRB-	23501
injury	23501
Kakulas , 1984 ; Geisler et al. , 1991	23509
Kakulas	23509
1984 ; Geisler et al.	23518
1984	23518
Geisler et al.	23524
Geisler	23524
et al.	23532
1991	23540
this reason	23551
several experimental models	23564
spinal cord lesions	23633
regeneration	23666
spinal cords	23701
Experimental models	23715
the compression type of acute cord trauma	23757
the compression type	23757
acute cord trauma	23781
the weight-dropping technique -LRB- Allen , 1911 ; Basso et al. , 1995 , 1996 -RRB- , extradural inflatable balloon compression -LRB- Tarlov et al. , 1953 -RRB- , and aneurysm clip compression -LRB- Rivlin and Tator , 1978 ; Fehlings and Tator , 1995 -RRB-	23807
the weight-dropping technique	23807
Allen , 1911 ; Basso et al. , 1995 , 1996	23838
Allen	23838
1911 ; Basso et al. , 1995	23845
1911	23845
Basso et al. , 1995	23851
Basso	23851
et al. , 1995	23857
et al.	23857
1995	23865
1996	23871
extradural inflatable balloon compression -LRB- Tarlov et al. , 1953 -RRB- , and aneurysm clip compression -LRB- Rivlin and Tator , 1978 ; Fehlings and Tator , 1995 -RRB-	23878
extradural inflatable balloon compression -LRB- Tarlov et al. , 1953 -RRB-	23878
extradural inflatable balloon compression	23878
Tarlov	23921
et al. , 1953	23928
et al.	23928
1953	23936
aneurysm clip compression -LRB- Rivlin and Tator , 1978 ; Fehlings and Tator , 1995 -RRB-	23947
aneurysm clip compression	23947
Rivlin and Tator	23974
Rivlin	23974
Tator	23985
1978 ; Fehlings and Tator , 1995	23992
1978	23992
Fehlings and Tator , 1995	23998
Fehlings and Tator	23998
1995	24018
contusion or compression trauma to the spinal cord	24031
contusion or compression trauma	24031
the spinal cord	24066
sequential pathological changes including hemorrhage , edema , axonal and neuronal necrosis , and demyelination followed by cystic formation	24083
sequential pathological changes	24083
hemorrhage , edema , axonal and neuronal necrosis , and demyelination followed by cystic formation	24125
hemorrhage , edema	24125
hemorrhage	24125
edema	24137
axonal and neuronal necrosis	24144
demyelination followed by cystic formation	24178
demyelination	24178
cystic formation	24204
the lesion site -LRB- Schwab and Bartholdi , 1996 ; Taoka and Okajima , 1998 ; McGraw et al. , 2001 -RRB-	24238
the lesion site	24238
Schwab and Bartholdi , 1996 ; Taoka and Okajima , 1998 ; McGraw et al. , 2001	24255
Schwab and Bartholdi	24255
1996 ; Taoka and Okajima , 1998 ; McGraw et al.	24277
1996	24277
Taoka and Okajima , 1998 ; McGraw et al.	24283
Taoka and Okajima , 1998	24283
Taoka and Okajima	24283
1998	24302
et al.	24315
2001	24323
15 and 30 min posttrauma	24338
15	24338
30 min posttrauma	24345
small hemorrhages with extravasation of erythrocytes and plasma into the perivascular spaces	24364
small hemorrhages	24364
extravasation of erythrocytes and plasma into the perivascular spaces	24387
extravasation	24387
erythrocytes and plasma	24404
the perivascular spaces	24433
2 to 7 days	24476
massive number of macrophages and other polymorphonucleate cells	24489
massive number	24489
macrophages and other polymorphonucleate cells	24507
macrophages	24507
other polymorphonucleate cells	24523
the lesion site	24561
Swollen axons with or without myelin	24578
Swollen axons	24578
myelin	24608
the first few days	24645
injury	24670
Several days	24678
the hemorrhagic zone	24698
cavitation and the adjacent areas	24725
cavitation	24725
the adjacent areas	24740
patchy necrosis , often with sharply defined margins	24767
patchy necrosis	24767
margins	24811
3 -- 5 days after injury	24827
3	24827
5 days after injury	24829
5 days	24829
injury	24842
reactive astrocytes	24850
wall	24879
the lesioned region	24888
Astrocytes	24909
this	24931
the expression of the structural protein GFAP	24950
the expression	24950
the structural protein GFAP	24968
the adjacent undamaged parenchyma toward the injured site	25012
the adjacent undamaged parenchyma	25012
the injured site	25053
their processes	25099
the reactive astrocytes around the lesioned area	25130
the reactive astrocytes	25130
the lesioned area	25161
leptomeningeal cells , which are normally found on the surface of the CNS , as well as fibroblasts ,	25180
leptomeningeal cells	25180
the surface of the CNS , as well as fibroblasts	25230
the surface of the CNS	25230
the surface	25230
the CNS	25245
fibroblasts	25265
the wound cavity and aid in the reformation of the basal lamina	25291
the wound cavity and aid	25291
the reformation of the basal lamina	25319
the reformation	25319
the basal lamina	25338
All these cells	25356
the named gliotic scar that isolates the necrotic cord parenchyma from the rest of undamaged spinal cord	25383
the named gliotic scar	25383
the necrotic cord parenchyma	25420
the rest of undamaged spinal cord	25454
the rest	25454
undamaged spinal cord	25466
The photochemical method of spinal cord damage	25489
The photochemical method	25489
spinal cord damage	25517
histopathological similarities with contusion and compression experimental lesions	25540
histopathological similarities	25540
contusion and compression experimental lesions	25576
previous studies	25627
we	25645
the first 60 min posttrauma	25669
light and electron microscopy	25698
an important cytotoxic edema	25735
astrocytic swelling , hemorrhagic extravasation , and myelin degradation in the lesion site	25769
astrocytic swelling	25769
hemorrhagic extravasation	25790
myelin degradation in the lesion site	25821
myelin degradation	25821
the lesion site	25843
15 days	25866
a cavity	25875
the necrotic area	25900
heavily GFAP	25938
heavily	25938
proteoglycan	25956
astrocytes	25978
this cavity -LRB- Verdu ' et al. , 2001 , 2002 -RRB-	26010
this cavity	26010
Verdu ' et al.	26023
Verdu ' et	26023
Verdu '	26023
et	26030
al.	26033
2001 , 2002	26038
2001	26038
2002	26044
A photochemical lesion in adult rats	26051
A photochemical lesion	26051
adult rats	26077
severity of spinal cord injury	26106
severity	26106
spinal cord injury	26118
the illumination time	26152
functional , electrophysiological , and morphological consequences	26175
Animals	26271
1 min	26294
small spinal cavities	26307
the dorsal funiculi	26339
The cavity	26360
dorsal horns	26407
animals irradiated for 2.5 min , the dorsolateral funiculi also in animals irradiated 5 min and even the ventrolateral funiculi in those irradiated for 10 min -LRB- Verdu ' et al. , 2002 -RRB-	26423
animals irradiated for 2.5 min	26423
animals	26423
2.5 min	26446
the dorsolateral funiculi also in animals irradiated 5 min	26455
dorsolateral funiculi	26459
animals	26489
the ventrolateral funiculi	26523
those irradiated for 10	26553
those irradiated	26553
10	26574
min -LRB- Verdu ' et al. , 2002 -RRB-	26577
min	26577
Verdu ' et al. , 2002	26582
Verdu '	26582
et al. , 2002	26589
et al.	26589
2002	26597
A significant negative relationship	26604
the area of cavity of the spinal cord and the functional and electrophysiological impairment -LRB- Garcı ' a-Alı ' as et al. , 2002 -RRB-	26658
the area	26658
cavity of the spinal cord and the functional and electrophysiological impairment -LRB- Garcı ' a-Alı ' as et al. , 2002 -RRB-	26670
cavity of the spinal cord	26670
cavity	26670
the spinal cord	26680
the functional and electrophysiological impairment -LRB- Garcı ' a-Alı ' as et al. , 2002 -RRB-	26700
the functional and electrophysiological impairment	26700
Garcı ' a-Alı ' as et al. , 2002	26752
Garcı '	26752
a-Alı ' as et al. , 2002	26758
a-Alı	26758
et al.	26767
2002	26775
This experimental model	26782
different therapeutic strategies	26857
neuroprotection and central regeneration	26901
neuroprotection	26901
central regeneration	26921
The ability of the OECs to promote axonal regeneration	26943
The ability	26943
the OECs	26958
axonal regeneration	26978
several regions of the central nervous system	27023
several regions	27023
the central nervous system	27042
Transplants of cultured OECs mediate the reentry of regenerating dorsal root axons into the dorsal gray matter -LRB- Ramo ' n-Cueto and Nieto-Sampedro , 1994 -RRB- and the synapses formed by these regenerating sensory fibers	27070
Transplants	27070
OECs	27094
the reentry of regenerating dorsal root axons into the dorsal gray matter -LRB- Ramo ' n-Cueto and Nieto-Sampedro , 1994 -RRB- and the synapses formed by these regenerating sensory fibers	27107
the reentry	27107
dorsal root axons	27135
the dorsal gray matter -LRB- Ramo ' n-Cueto and Nieto-Sampedro , 1994 -RRB- and the synapses formed by these regenerating sensory fibers	27158
the dorsal gray matter -LRB- Ramo ' n-Cueto and Nieto-Sampedro , 1994 -RRB-	27158
the dorsal gray matter	27158
Ramo ' n-Cueto and Nieto-Sampedro , 1994	27182
Ramo ' n-Cueto and Nieto-Sampedro	27182
Ramo '	27182
1994	27215
the synapses formed by these regenerating sensory fibers	27225
the synapses	27225
these regenerating sensory fibers	27248
functional restitution of spinal reflex arcs -LRB- Navarro et al. , 1999 ; Taylor et al. , 2001 -RRB-	27290
functional restitution	27290
spinal reflex arcs -LRB- Navarro et al. , 1999 ; Taylor et al. , 2001 -RRB-	27316
spinal reflex arcs	27316
Navarro	27336
et al. , 1999 ; Taylor et al. , 2001	27344
et al.	27344
1999 ; Taylor et al.	27352
1999	27352
Taylor et al.	27358
Taylor	27358
et al.	27365
2001	27373
the corticospinal tract	27385
OECs transplanted into the lesion site	27431
OECs	27431
the lesion site	27454
the elongation of corticospinal axons	27479
the elongation	27479
corticospinal axons	27497
the transplanted area -LRB- Li et al. , 1998 -RRB-	27527
the transplanted area	27527
Li	27550
et al. , 1998	27553
et al.	27553
1998	27561
Functional recovery in OECs-transplanted rats in comparison with vehicle-injected animals	27568
Functional recovery	27568
OECs-transplanted rats in comparison with vehicle-injected animals	27591
OECs-transplanted rats	27591
comparison with vehicle-injected animals	27617
comparison	27617
vehicle-injected animals	27633
complete transection of the adult rat spinal cord	27687
complete transection	27687
the adult rat spinal cord	27711
Ramo ' n-Cueto et al. -LRB- 2000 -RRB-	27738
Ramo ' n-Cueto et al.	27738
Ramo ' n-Cueto	27738
Ramo '	27738
et al.	27751
2000	27759
7 months after surgery , about 20 % of OECs-transplanted rats	27779
7 months	27779
surgery , about 20 % of OECs-transplanted rats	27794
surgery	27794
20 % of OECs-transplanted rats	27809
20 %	27809
OECs-transplanted rats	27816
a grid	27850
a slope of 90 °	27862
a slope	27862
90 °	27873
none of the DMEM-injected rats	27886
none	27886
the DMEM-injected rats	27894
this test	27924
addition	27938
OECs-transplanted rats	27948
positive responses	27978
light skin contact and propioceptive stimuli 7 months postsurgery	28000
light skin contact	28000
propioceptive stimuli 7 months postsurgery	28023
propioceptive stimuli 7 months	28023
propioceptive stimuli	28023
7 months	28045
postsurgery	28054
interest	28070
the functional recovery observed in the OECs-transplanted group compared to that in the DMEM group	28087
the functional recovery	28087
the OECs-transplanted group	28123
that in the DMEM group	28163
that	28163
the DMEM group	28171
3 months postoperation -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	28208
3 months	28208
postoperation -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	28217
postoperation	28217
Ramo ' n-Cueto et al. , 2000	28232
Ramo ' n-Cueto et al.	28232
Ramo ' n-Cueto	28232
Ramo '	28232
et al.	28245
2000	28253
Lu et al. -LRB- 2001 -RRB-	28260
Lu et al.	28260
Lu	28260
et al.	28263
2001	28271
complete spinal cord transection at T10	28303
complete spinal cord transection	28303
T10	28339
OECs-transplanted rats	28344
hindlimb usage	28376
the openfield walking test	28398
they	28426
8 -- 10 weeks postsurgery	28445
8	28445
10 weeks	28447
OECs-transplanted rats	28469
a BBB score	28500
6 -- 8 , whereas the BBB score of the nontransplanted rats averaged only 2	28521
6 -- 8	28521
the BBB score of the nontransplanted rats	28534
the BBB score	28534
the nontransplanted rats	28551
only 2	28585
Shen et al. -LRB- 2002 -RRB-	28603
Shen et al.	28603
Shen	28603
et al.	28608
2002	28616
10 weeks after spinal cord transection	28639
10 weeks	28639
spinal cord transection	28654
5 of 12 OECs-transplanted rats	28679
5	28679
12 OECs-transplanted rats	28684
recordable motor-evoked potentials	28717
none of the rats that received DMEM alone	28761
none	28761
the rats that received DMEM alone	28769
the rats	28769
DMEM	28792
MEPs	28807
All these findings	28813
OECs transplanted in severe spinal cord injuries	28849
OECs	28849
severe spinal cord injuries	28870
functional recovery	28906
Several factors	28927
the abilities of OECs	28955
the abilities	28955
OECs	28972
regeneration of central axons and functional recovery	28988
regeneration	28988
central axons and functional recovery	29004
central axons	29004
functional recovery	29022
spinal cord injuries	29048
OECs	29086
nerve	29099
growth factor -LRB- NGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- , glia cell line-derived neurotrophic factor -LRB- GDNF -RRB- , and their receptors -LRB- Woodhall et al. , 2001 -RRB-	29105
growth factor	29105
NGF	29120
brain-derived neurotrophic factor -LRB- BDNF -RRB- , glia cell line-derived neurotrophic factor -LRB- GDNF -RRB- , and their receptors -LRB- Woodhall et al. , 2001 -RRB-	29126
brain-derived neurotrophic factor -LRB- BDNF -RRB-	29126
brain-derived neurotrophic factor	29126
BDNF	29161
glia cell line-derived neurotrophic factor -LRB- GDNF -RRB-	29168
glia cell line-derived neurotrophic factor	29168
glia cell	29168
line-derived neurotrophic factor	29178
GDNF	29212
their receptors -LRB- Woodhall et al. , 2001 -RRB-	29223
their receptors	29223
Woodhall	29240
et al. , 2001	29249
et al.	29249
2001	29257
OECs	29264
neurotrophin 4/5 -LRB- Boruch et al. , 2001 -RRB- and p-75 low-affinity NGF receptor -LRB- Ramo ' n-Cueto et al. , 1993 -RRB-	29282
neurotrophin 4/5	29282
Boruch	29300
et al. , 2001	29307
et al.	29307
2001	29315
p-75 low-affinity NGF receptor -LRB- Ramo ' n-Cueto et al. , 1993 -RRB-	29325
p-75	29325
low-affinity NGF receptor -LRB- Ramo ' n-Cueto et al. , 1993 -RRB-	29330
low-affinity NGF receptor	29330
Ramo ' n-Cueto et al. , 1993	29357
Ramo ' n-Cueto et al.	29357
Ramo ' n-Cueto	29357
Ramo '	29357
et al.	29370
1993	29378
It	29385
all these neurotrophic factors	29407
sprouting and regeneration of central axons	29446
sprouting and regeneration	29446
central axons	29476
sensory axons	29509
NGF , BDNF , and neurotrophin	29541
NGF	29541
BDNF	29546
neurotrophin	29556
3 -LRB- NT-3 -RRB- -LRB- Bradbury et al. , 1999 ; Oudega and Hagg , 1999 -RRB-	29569
3 -LRB- NT-3 -RRB-	29569
Bradbury	29579
et al. , 1999 ; Oudega and Hagg , 1999	29588
et al.	29588
1999 ; Oudega and Hagg	29596
1999	29596
Oudega and Hagg	29602
1999	29619
Lesioned rubrospinal and corticospinal axons	29626
Lesioned rubrospinal	29626
corticospinal axons	29651
BDNF , which promotes regeneration of rubrospinal axons -LRB- Liu et al. , 1999 ; Plunet et al. , 2002 -RRB- and survival but not regrowth of lesioned corticospinal axons -LRB- Lu et al. , 2001 -RRB-	29694
BDNF	29694
regeneration of rubrospinal axons -LRB- Liu et al. , 1999 ; Plunet et al. , 2002 -RRB- and survival but not regrowth of lesioned corticospinal axons -LRB- Lu et al. , 2001 -RRB-	29715
regeneration of rubrospinal axons -LRB- Liu et al. , 1999 ; Plunet et al. , 2002 -RRB- and survival	29715
regeneration	29715
rubrospinal axons -LRB- Liu et al. , 1999 ; Plunet et al. , 2002 -RRB- and survival	29731
rubrospinal axons -LRB- Liu et al. , 1999 ; Plunet et al. , 2002 -RRB-	29731
rubrospinal axons	29731
Liu	29750
et al. , 1999 ; Plunet et al. , 2002	29754
et al.	29754
1999 ; Plunet et al.	29762
1999	29762
Plunet et al.	29768
Plunet	29768
et al.	29775
2002	29783
survival	29793
regrowth of lesioned corticospinal axons -LRB- Lu et al. , 2001 -RRB-	29810
regrowth	29810
lesioned corticospinal axons -LRB- Lu et al. , 2001 -RRB-	29822
lesioned corticospinal axons	29822
Lu	29852
et al. , 2001	29855
et al.	29855
2001	29863
NT-4	29870
5	29875
atrophy of rat rubrospinal neurons	29886
atrophy	29886
rat rubrospinal neurons	29897
axotomy	29927
rubrospinal regeneration -LRB- Kobayashi et al. , 1997 -RRB-	29948
rubrospinal regeneration	29948
Kobayashi	29974
et al. , 1997	29984
et al.	29984
1997	29992
GDNF	29999
survival and axonal regeneration of noradrenergic neurons of the locus coeruleus -LRB- Arenas et al. , 1995 ; Holm et al 2002 -RRB-	30013
survival and axonal regeneration	30013
noradrenergic neurons of the locus coeruleus -LRB- Arenas et al. , 1995 ; Holm et al 2002 -RRB-	30049
noradrenergic neurons	30049
the locus coeruleus -LRB- Arenas et al. , 1995 ; Holm et al 2002 -RRB-	30074
the locus coeruleus	30074
Arenas	30095
et al. , 1995 ; Holm et al 2002	30102
et al. , 1995 ; Holm et al	30102
et al. , 1995	30102
et al.	30102
1995	30110
Holm et al	30116
Holm	30116
et al	30121
2002	30127
addition	30137
OECs	30147
molecules known to be involved in neurite extension such as L1 , laminin , N-CAM , PSA-NCAM , and fibronectin -LRB- Ramo ' n-Cueto and Avila , 1998 -RRB-	30160
molecules	30160
neurite extension such as L1 , laminin , N-CAM , PSA-NCAM , and fibronectin -LRB- Ramo ' n-Cueto and Avila , 1998 -RRB-	30194
neurite extension	30194
L1 , laminin , N-CAM , PSA-NCAM , and fibronectin -LRB- Ramo ' n-Cueto and Avila , 1998 -RRB-	30220
L1 , laminin , N-CAM , PSA-NCAM , and fibronectin	30220
Ramo ' n-Cueto and Avila , 1998	30267
Ramo ' n-Cueto	30267
Ramo '	30267
n-Cueto	30272
Avila , 1998	30284
Avila	30284
1998	30291
These findings	30298
OECs	30326
the survival and regeneration of the main	30356
the survival and regeneration	30356
the main	30389
pathways in the adult spinal cord	30423
pathways	30423
the adult spinal cord	30435
it	30467
OECs transplanted into the lesioned cord also	30484
OECs	30484
the lesioned cord also	30507
the	30507
cord	30520
all these neurotrophic factors	30550
OECs transplanted in lesioned spinal cords	30592
OECs	30592
lesioned spinal cords	30613
a downregulation of GFAP and proteoglycan expression	30642
a downregulation	30642
GFAP and proteoglycan expression	30662
the reactive astrocytes -LRB- Verdu ' et al. , 2001 -RRB-	30698
reactive astrocytes -LRB- Verdu ' et al. , 2001 -RRB-	30702
reactive astrocytes	30702
Verdu ' et al. , 2001	30723
Verdu '	30723
et al. , 2001	30730
et al.	30730
2001	30738
the present study	30748
we	30767
these results	30778
a longer time , 3 months postlesion , when the injury process has reached a steady state	30795
a longer time	30795
3 months postlesion	30810
3 months	30810
postlesion	30819
the injury process	30836
a steady state	30867
Studies that have used cocultures with astrocytes	30883
Studies	30883
cocultures	30906
astrocytes	30922
OECs	30945
overexpression of chondroitin sulfate proteoglycans -LRB- CSPGs -RRB-	30965
overexpression	30965
chondroitin sulfate proteoglycans -LRB- CSPGs -RRB-	30983
chondroitin sulfate proteoglycans	30983
CSPGs	31018
astrocytes	31028
Schwann cells	31059
CSPG expression	31083
astrocytes -LRB- Lakatos et al. , 2000 , 2002 -RRB-	31102
astrocytes	31102
Lakatos	31114
et al. , 2000 , 2002	31122
et al.	31122
2000	31130
2002	31136
In vitro studies	31143
proteoglycan	31178
neurite outgrowth	31200
a monoclonal antibody against proteoglycan	31228
a monoclonal antibody	31228
proteoglycan	31258
this inhibitory activity -LRB- Bovolenta et al. , 1997 -RRB-	31283
this inhibitory activity	31283
Bovolenta	31309
et al. , 1997	31319
et al.	31319
1997	31327
Plant et al. -LRB- 2001 -RRB-	31344
Plant et al.	31344
Plant	31344
et al.	31350
2001	31358
CSPG immunoreactivity	31378
the graft-host cord interface	31417
it	31452
astrocytes and fibroblasts	31475
These findings	31503
accumulation of proteoglycan compounds near the wound	31531
accumulation	31531
proteoglycan compounds near the wound	31547
proteoglycan compounds	31547
the wound	31575
the elongation of injured central axons	31596
the elongation	31596
injured central axons	31614
fact	31640
chondroitinase-ABC treatment , which degrades CSPGs ,	31646
chondroitinase-ABC treatment	31646
CSPGs	31691
neurite elongation -LRB- Zuo et al. , 1998 -RRB-	31705
neurite elongation	31705
Zuo	31725
et al. , 1998	31729
et al.	31729
1998	31737
axonal regeneration	31756
spinal cord injury -LRB- Yick et al. , 2000 ; Bradbury et al. , 2002 -RRB-	31782
spinal cord injury	31782
Yick	31802
et al. , 2000 ; Bradbury et al. , 2002	31807
et al.	31807
2000 ; Bradbury et al.	31815
2000	31815
Bradbury et al.	31821
Bradbury	31821
et al.	31830
2002	31838
Our results -LRB- Verdu ' et al. , 2001 -RRB- suggest that OECs directly or indirectly modulate reactive astrocytes , reducing their reactivity and creating a protective environment .	31845
Our results -LRB- Verdu ' et al. , 2001 -RRB-	31845
results -LRB- Verdu ' et al. , 2001 -RRB-	31849
results	31849
Verdu ' et al. , 2001	31858
Verdu '	31858
et al. , 2001	31865
et al.	31865
2001	31873
OECs	31892
reactive astrocytes	31929
their reactivity	31959
a protective environment	31989
We	32015
OECs	32038
other cells , such as microglia and leukocytes , which infiltrate the cord parenchyma during the first hours after injury , modulating their proinflammatory response	32064
other cells	32064
microglia and leukocytes , which infiltrate the cord parenchyma during the first hours after injury , modulating their proinflammatory response	32085
microglia and leukocytes	32085
the cord parenchyma	32128
the first hours after injury	32155
the first hours	32155
injury	32177
their proinflammatory response	32196
The preservation of more cord parenchyma by transplanted OECs after the photochemical spinal cord injury -LRB- Verdu ' et al. , 2001 -RRB- , confirmed in the present work ,	32228
The preservation	32228
more cord parenchyma by transplanted OECs after the photochemical spinal cord injury -LRB- Verdu ' et al. , 2001 -RRB- , confirmed in the present work ,	32248
more cord parenchyma	32248
transplanted OECs after the photochemical spinal cord injury -LRB- Verdu ' et al. , 2001 -RRB- , confirmed in the present work ,	32272
transplanted OECs	32272
the photochemical spinal cord injury -LRB- Verdu ' et al. , 2001 -RRB- , confirmed in the present work ,	32296
the photochemical spinal cord injury -LRB- Verdu ' et al. , 2001 -RRB-	32296
the photochemical spinal cord injury	32296
Verdu ' et al. , 2001	32334
Verdu '	32334
et al. , 2001	32341
et al.	32341
2001	32349
the present work	32369
the proregenerative and promodulating inflammatory properties of OECs	32412
the proregenerative and promodulating inflammatory properties	32412
OECs	32477
the effects of OECs	32492
the effects	32492
OECs	32507
their ability to migrate inside the spinal cord parenchyma	32536
the spinal cord parenchyma	32568
a previous study	32599
we	32617
OECs	32647
T12-L1 spinal cord levels	32669
OECs	32696
rostral -LRB- T9 -- T10 -RRB- and caudal -LRB- L4 -- L6 -RRB- spinal cord levels	32722
rostral -LRB- T9 -- T10 -RRB-	32722
rostral	32722
T9 -- T10	32731
T9	32731
T10	32734
caudal -LRB- L4 -- L6 -RRB- spinal cord levels	32743
caudal	32743
L4 -- L6	32751
L4	32751
L6	32754
spinal cord levels	32758
15 days	32777
spinal cord injury and transplantation -LRB- Verdu ' et al. , 2001 -RRB-	32791
spinal cord injury	32791
transplantation -LRB- Verdu ' et al. , 2001 -RRB-	32814
transplantation	32814
Verdu ' et al. , 2001	32831
Verdu '	32831
et al. , 2001	32838
et al.	32838
2001	32846
Boruch et al. -LRB- 2001 -RRB-	32853
Boruch et al.	32853
Boruch	32853
et al.	32860
2001	32868
1 month after dorsal hemisection , p75-positive OECs	32893
1 month	32893
dorsal hemisection , p75-positive OECs	32907
dorsal hemisection	32907
p75-positive OECs	32927
the injured dorsal aspect	32973
the uninjured ventral portion of the spinal cord	33017
the uninjured ventral portion	33017
the spinal cord	33050
addition	33070
OECs migration	33080
transplantation in the hippocampus -LRB- Gudin˜ o-Cabrera and Nieto-Sampedro , 1996 -RRB-	33114
transplantation	33114
the hippocampus -LRB- Gudin˜ o-Cabrera and Nieto-Sampedro , 1996 -RRB-	33133
the hippocampus	33133
Gudin˜ o-Cabrera and Nieto-Sampedro , 1996	33150
Gudin˜ o-Cabrera and Nieto-Sampedro	33150
1996	33187
the transected medial longitudinal fascicle -LRB- Gudin˜ o-Cabrera et al. , 2000 -RRB-	33203
the	33203
medial longitudinal fascicle -LRB- Gudin˜ o-Cabrera et al. , 2000 -RRB-	33218
medial longitudinal fascicle	33218
Gudin˜ o-Cabrera	33248
et al. , 2000	33265
et al.	33265
2000	33273
the other hand	33283
previous studies	33299
transplanted OECs	33335
2 -LRB- Gudin˜ o-Cabrera et al. , 2000 -RRB- or 7 months -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	33366
2 -LRB- Gudin˜ o-Cabrera et al. , 2000 -RRB-	33366
2	33366
Gudin˜ o-Cabrera	33369
et al. , 2000	33386
et al.	33386
2000	33394
7 months -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	33403
7 months	33403
Ramo ' n-Cueto et al. , 2000	33413
Ramo ' n-Cueto et al.	33413
Ramo ' n-Cueto	33413
Ramo '	33413
et al.	33426
2000	33434
transplantation	33446
All these findings	33463
OECs	33504
large distances	33541
the central nervous system	33578
conclusion	33609
OEC transplantation	33621
a promising therapeutic procedure	33653
injured spinal cords	33701
The results reported in the present study	33723
The results	33723
the present study	33747
the first evidence	33773
transplants of OECs	33797
transplants	33797
OECs	33812
loss of cord parenchyma	33825
loss	33825
cord parenchyma	33833
functional recovery	33861
incomplete spinal cord injury , the main type of human spinal cord injury	33887
incomplete spinal cord injury	33887
the main type of human spinal cord injury	33918
the main type	33918
human spinal cord injury	33935
the clinical use of this therapeutic procedure	33970
the clinical use	33970
this therapeutic procedure	33990
further studies in animal models	34026
further studies	34026
animal models	34045
